Trial to Optimally Show the Pharmacological Action of Z-100
Status:
Active, not recruiting
Trial end date:
2022-10-01
Target enrollment:
Participant gender:
Summary
The objective of this clinical trial is to evaluate the change of the immunological parameter
levels in FIGO stage IIIB cervical cancer subjects by administration of Z-100